129 related articles for article (PubMed ID: 6420930)
1. Purification and some properties of a protein obtained from normal human plasma which inhibits the platelet aggregation induced by thrombotic thrombocytopenic purpura plasma.
Lian EC; Mui PT; Siddiqui FA; Chiu LL
Thromb Res; 1984 Jan; 33(1):69-76. PubMed ID: 6420930
[TBL] [Abstract][Full Text] [Related]
2. Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma.
Siddiqui FA; Lian EC
J Clin Invest; 1985 Oct; 76(4):1330-7. PubMed ID: 3932464
[TBL] [Abstract][Full Text] [Related]
3. [Purification and some properties of platelet aggregating protein (PAP) from the plasma of a patient with thrombotic thrombocytopenic purpura].
Chen SH
Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):382-4, 28. PubMed ID: 2598093
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G.
Lian EC; Mui PT; Siddiqui FA; Chiu AY; Chiu LL
J Clin Invest; 1984 Feb; 73(2):548-55. PubMed ID: 6538207
[TBL] [Abstract][Full Text] [Related]
5. Characterization of platelet agglutinating protein p37 purified from the plasma of a patient with thrombotic thrombocytopenic purpura.
Siddiqui FA; Lian EC
Biochem Mol Biol Int; 1993 Jun; 30(2):385-95. PubMed ID: 8364416
[TBL] [Abstract][Full Text] [Related]
6. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
Moore JC; Murphy WG; Kelton JG
Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
[TBL] [Abstract][Full Text] [Related]
7. [Thrombotic thrombocytopenic purpura (Moschcowitz syndrome) in a patient with EPH gestosis. The pathophysiologic principle of HELLP syndrome? On the question of the identity of the HELLP syndrome with thrombotic thrombocytopenic purpura].
Staiger HJ; Fettig O; Theml H
Geburtshilfe Frauenheilkd; 1989 Jun; 49(6):597-600. PubMed ID: 2663622
[TBL] [Abstract][Full Text] [Related]
8. The platelet aggregating factor(s) of thrombotic thrombocytopenic purpura.
Kelton JG; Moore JC; Murphy WG
Prog Clin Biol Res; 1990; 337():141-9. PubMed ID: 2191308
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Moake JL; McPherson PD
Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
[TBL] [Abstract][Full Text] [Related]
10. Platelet-agglutinating protein p37 from a patient with thrombotic thrombocytopenic purpura has characteristics similar to prethrombin 2.
Kim SH; Park SJ; Lee JW; Jin JY
J Biochem Mol Biol; 2002 Sep; 35(5):524-31. PubMed ID: 12359097
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
12. Platelet-agglutinating protein P37 from a thrombotic thrombocytopenic purpura plasma forms a complex with human immunoglobulin G.
Siddiqui FA; Lian EC
Blood; 1988 Feb; 71(2):299-304. PubMed ID: 3337898
[TBL] [Abstract][Full Text] [Related]
13. Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma.
Lian EC; Harkness DR; Byrnes JJ; Wallach H; Nunez R
Blood; 1979 Feb; 53(2):333-8. PubMed ID: 570069
[TBL] [Abstract][Full Text] [Related]
14. Electron microscopic study of platelet agglutination induced by thrombotic thrombocytopenic purpura plasma containing 37-KDa platelet agglutinating protein.
Li JZ; Liu JW; Benito G; Siddiqui FA; Lian EC
Thromb Res; 1989 Sep; 55(6):757-66. PubMed ID: 2781535
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic thrombocytopenic purpura--a syndrome caused by multiple pathogenetic mechanisms.
Lian EC
Invest Clin; 2001 May; 42 Suppl 1():75-86. PubMed ID: 11416985
[TBL] [Abstract][Full Text] [Related]
16. Platelet aggregating factor in the epidemic form of hemolytic-uremic syndrome in childhood.
Monnens L; van de Meer W; Langenhuysen C; van Munster P; van Oostrom C
Clin Nephrol; 1985 Sep; 24(3):135-7. PubMed ID: 4042442
[TBL] [Abstract][Full Text] [Related]
17. Purification of porcine and human ristocetin-Willebrand factor.
Olson JD; Brockway WJ; Fass DN; Bowie EJ; Mann KG
J Lab Clin Med; 1977 Jun; 89(6):1278-94. PubMed ID: 405441
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD36 antibodies in thrombotic thrombocytopenic purpura.
Tandon NN; Rock G; Jamieson GA
Br J Haematol; 1994 Dec; 88(4):816-25. PubMed ID: 7529543
[TBL] [Abstract][Full Text] [Related]
19. Morphological platelet anomalies in thrombotic thrombocytopenic purpura.
Aderka D; Djaldetti M; Shoenfeld Y; Shaklai M; Santo M; Berliner S; Weinberger A; Pinkhas J
Acta Haematol; 1982; 67(2):119-23. PubMed ID: 6801893
[TBL] [Abstract][Full Text] [Related]
20. Effects of platelet inhibitors on the platelet aggregation induced by plasma from patients with thrombotic thrombocytopenic purpura.
Lian EC; Savaraj N
Blood; 1981 Aug; 58(2):354-9. PubMed ID: 6264998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
